TR200101345T2 - Hipoksiya'nın oluşturabildiği faktör 1alfa HIF-1alfa'nın değişik biçimleri için yöntemler. - Google Patents
Hipoksiya'nın oluşturabildiği faktör 1alfa HIF-1alfa'nın değişik biçimleri için yöntemler.Info
- Publication number
- TR200101345T2 TR200101345T2 TR2001/01345T TR200101345T TR200101345T2 TR 200101345 T2 TR200101345 T2 TR 200101345T2 TR 2001/01345 T TR2001/01345 T TR 2001/01345T TR 200101345 T TR200101345 T TR 200101345T TR 200101345 T2 TR200101345 T2 TR 200101345T2
- Authority
- TR
- Turkey
- Prior art keywords
- alpha
- human hif
- hif
- essentially
- domain
- Prior art date
Links
- 206010021143 Hypoxia Diseases 0.000 title 1
- 230000007954 hypoxia Effects 0.000 title 1
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 abstract 8
- 102000049131 human HIF1A Human genes 0.000 abstract 8
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000040945 Transcription factor Human genes 0.000 abstract 2
- 108091023040 Transcription factor Proteins 0.000 abstract 2
- 230000003081 coactivator Effects 0.000 abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000030648 nucleus localization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Amplifiers (AREA)
- Semiconductor Lasers (AREA)
- Radar Systems Or Details Thereof (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803891A SE9803891D0 (sv) | 1998-11-13 | 1998-11-13 | Protein Variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200101345T2 true TR200101345T2 (tr) | 2001-10-22 |
Family
ID=20413284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/01345T TR200101345T2 (tr) | 1998-11-13 | 1999-11-11 | Hipoksiya'nın oluşturabildiği faktör 1alfa HIF-1alfa'nın değişik biçimleri için yöntemler. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1141005B1 (https=) |
| JP (1) | JP2002530063A (https=) |
| KR (1) | KR100648761B1 (https=) |
| CN (1) | CN1330666C (https=) |
| AT (1) | ATE374210T1 (https=) |
| AU (1) | AU761594B2 (https=) |
| BR (1) | BR9915263A (https=) |
| CA (1) | CA2350830A1 (https=) |
| DE (1) | DE69937199D1 (https=) |
| HK (1) | HK1043372B (https=) |
| NZ (1) | NZ511450A (https=) |
| SE (1) | SE9803891D0 (https=) |
| TR (1) | TR200101345T2 (https=) |
| WO (1) | WO2000029437A1 (https=) |
| ZA (1) | ZA200103669B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9911047D0 (en) | 1999-05-12 | 1999-07-14 | Isis Innovation | Assay method and means |
| ATE383877T1 (de) * | 1999-06-04 | 2008-02-15 | Dana Farber Cancer Inst Inc | Identifikation von stoffen, die transkriptionelle antworten auf hypoxia modifizieren |
| WO2001092578A2 (en) * | 2000-05-26 | 2001-12-06 | Board Of Trustees Of The University Of Illinois | Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| AU9017901A (en) * | 2000-08-07 | 2002-02-18 | Angiogenetics Sweden Ab | Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the vonhippel-lindau tumor suppressor protein |
| US20030045830A1 (en) * | 2001-04-17 | 2003-03-06 | De Bizemont Therese | Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| AU2002302252A1 (en) | 2001-05-23 | 2002-12-03 | Angiogene Inc. | Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| EP1842856A3 (en) * | 2001-05-23 | 2007-12-12 | Angiogene Inc. | Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| AU2003201798A1 (en) * | 2002-01-11 | 2003-09-02 | Angio Genetics Sweden Ab | Hif-1 alpha proteins mutated in the c-terminal transactivation domain |
| CN100366747C (zh) * | 2005-03-08 | 2008-02-06 | 上海第二医科大学附属仁济医院 | 低氧诱导因子小干扰rna质粒 |
| CN100418574C (zh) * | 2005-10-26 | 2008-09-17 | 王成球 | 一类封闭人类HIF-1α基因和调控网络中下游相关基因的染色质肽 |
| CN102127161B (zh) * | 2010-12-16 | 2013-03-27 | 何明忠 | 抗肿瘤多肽及其用途 |
| CN106366173A (zh) * | 2015-07-24 | 2017-02-01 | 北京京爱康科技有限公司 | 一种通过结合低氧反应元件控制缺氧反应基因表达的染色质肽 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882914A (en) * | 1995-06-06 | 1999-03-16 | The Johns Hopkins University School Of Medicine | Nucleic acids encoding the hypoxia inducible factor-1 |
-
1998
- 1998-11-13 SE SE9803891A patent/SE9803891D0/xx unknown
-
1999
- 1999-11-11 WO PCT/SE1999/002053 patent/WO2000029437A1/en not_active Ceased
- 1999-11-11 KR KR1020017005928A patent/KR100648761B1/ko not_active Expired - Fee Related
- 1999-11-11 JP JP2000582422A patent/JP2002530063A/ja active Pending
- 1999-11-11 DE DE69937199T patent/DE69937199D1/de not_active Expired - Lifetime
- 1999-11-11 CN CNB99814388XA patent/CN1330666C/zh not_active Expired - Fee Related
- 1999-11-11 CA CA002350830A patent/CA2350830A1/en not_active Abandoned
- 1999-11-11 TR TR2001/01345T patent/TR200101345T2/xx unknown
- 1999-11-11 AU AU15931/00A patent/AU761594B2/en not_active Ceased
- 1999-11-11 AT AT99958594T patent/ATE374210T1/de not_active IP Right Cessation
- 1999-11-11 EP EP99958594A patent/EP1141005B1/en not_active Expired - Lifetime
- 1999-11-11 BR BR9915263-0A patent/BR9915263A/pt not_active Application Discontinuation
- 1999-11-11 HK HK02105080.8A patent/HK1043372B/zh not_active IP Right Cessation
- 1999-11-11 NZ NZ511450A patent/NZ511450A/en unknown
-
2001
- 2001-05-07 ZA ZA200103669A patent/ZA200103669B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200103669B (en) | 2002-05-07 |
| SE9803891D0 (sv) | 1998-11-13 |
| BR9915263A (pt) | 2001-10-30 |
| EP1141005A1 (en) | 2001-10-10 |
| HK1043372A1 (en) | 2002-09-13 |
| KR20010080411A (ko) | 2001-08-22 |
| CN1330666C (zh) | 2007-08-08 |
| AU761594B2 (en) | 2003-06-05 |
| KR100648761B1 (ko) | 2006-11-23 |
| WO2000029437A1 (en) | 2000-05-25 |
| CA2350830A1 (en) | 2000-05-25 |
| JP2002530063A (ja) | 2002-09-17 |
| HK1043372B (zh) | 2008-05-09 |
| DE69937199D1 (de) | 2007-11-08 |
| NZ511450A (en) | 2003-08-29 |
| ATE374210T1 (de) | 2007-10-15 |
| CN1330663A (zh) | 2002-01-09 |
| EP1141005B1 (en) | 2007-09-26 |
| AU1593100A (en) | 2000-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Franke et al. | Differences of expression of cytoskeletal proteins in cultured rat hepatocytes and hepatoma cells | |
| TR200101345T2 (tr) | Hipoksiya'nın oluşturabildiği faktör 1alfa HIF-1alfa'nın değişik biçimleri için yöntemler. | |
| KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
| DE69614198D1 (de) | EPR4 Postprozessor mit reduzierter Komplexität zur Detektion von abgetasteten Daten | |
| ATE224713T1 (de) | Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression | |
| DE60023936D1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
| HUP0100094A1 (hu) | Új felületi antigén | |
| BR9912545A (pt) | ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial | |
| DE69017921D1 (de) | Lactoferrinhydrolysat zur Verwendung als tyrosinagehemmendes Mittel. | |
| ATE382148T1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| DE69534252D1 (de) | Enzyme zur spaltung der verankerungsregion von oberflächenproteinen aus gram-positiven bakterien | |
| DE69926627D1 (de) | Insulinartigen wachstumsfaktor bindendes protein -3 variante | |
| DE60038363D1 (de) | Detektion von kleinen molekülen mit piezo-elektrischem sensor | |
| KR930023469A (ko) | 베타 아밀로이드 전구 단백질 프로세싱 효소의 검출 방법 | |
| WO2000020446A3 (en) | Bax-mediated apoptosis modulating reagents and methods | |
| ES2168816T3 (es) | Cemento de inyeccion que contiene inhibidores de la corrosion. | |
| BR9510067A (pt) | Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo | |
| ATE290088T1 (de) | Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms | |
| ATE405649T1 (de) | Hemmstoff zur diagnose und behandlung von haemophilia a patienten | |
| DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
| DE69927668D1 (de) | Massenfingerabdrucken und seiner verwendung zur identifizierung von protein-affinitätsliganden | |
| DE69629653D1 (de) | Methode zur bestimmung der ursache von defekten auf stahloberflächen | |
| AR007279A1 (es) | Composicion para la tincion y tonalizacion de cabellos | |
| DE58901435D1 (de) | Verfahren zur herstellung von dipeptiden mit n-terminalen nichtproteinogenen aminosaeuren. |